David R. Brenin

1.9k total citations
60 papers, 1.4k citations indexed

About

David R. Brenin is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, David R. Brenin has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cancer Research, 20 papers in Oncology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in David R. Brenin's work include Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (15 papers) and Advanced Radiotherapy Techniques (9 papers). David R. Brenin is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (15 papers) and Advanced Radiotherapy Techniques (9 papers). David R. Brenin collaborates with scholars based in United States, Germany and Sweden. David R. Brenin's co-authors include Anneke T. Schroen, Craig L. Slingluff, William A. Knaus, Maria D. Kelly, Philip M. Iannaccone, Kant Y. Lin, Shayna L. Showalter, Deborah A. Lannigan, Jennifer A. Harvey and Mahmoud El‐Tamer and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

David R. Brenin

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Brenin United States 20 529 467 432 316 280 60 1.4k
Judith Mills United Kingdom 10 877 1.7× 715 1.5× 364 0.8× 193 0.6× 325 1.2× 14 1.7k
F. Dravet France 23 610 1.2× 662 1.4× 806 1.9× 283 0.9× 409 1.5× 72 1.6k
Bengt Sorbe Sweden 30 248 0.5× 634 1.4× 761 1.8× 387 1.2× 234 0.8× 133 3.0k
Shelley Hwang United States 17 852 1.6× 500 1.1× 510 1.2× 117 0.4× 544 1.9× 34 1.5k
Carlos A. Garberoglio United States 23 309 0.6× 532 1.1× 522 1.2× 128 0.4× 269 1.0× 77 1.5k
Susan B. Kesmodel United States 19 346 0.7× 805 1.7× 268 0.6× 193 0.6× 136 0.5× 80 1.4k
Sara H. Javid United States 22 561 1.1× 533 1.1× 212 0.5× 202 0.6× 388 1.4× 61 1.5k
Sarah S. Mougalian United States 19 803 1.5× 599 1.3× 219 0.5× 66 0.2× 386 1.4× 67 1.3k
Janis Homewood United Kingdom 10 721 1.4× 500 1.1× 187 0.4× 107 0.3× 313 1.1× 12 1.4k
Thelma C. Hurd United States 21 686 1.3× 706 1.5× 399 0.9× 79 0.3× 388 1.4× 58 1.7k

Countries citing papers authored by David R. Brenin

Since Specialization
Citations

This map shows the geographic impact of David R. Brenin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Brenin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Brenin more than expected).

Fields of papers citing papers by David R. Brenin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Brenin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Brenin. The network helps show where David R. Brenin may publish in the future.

Co-authorship network of co-authors of David R. Brenin

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Brenin. A scholar is included among the top collaborators of David R. Brenin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Brenin. David R. Brenin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moheb, Mohamad El, et al.. (2025). An Open-architecture AI Model for CPT Coding in Breast Surgery. Annals of Surgery. 282(3). 439–448.
2.
Han, Samuel, et al.. (2023). Identifying the effectiveness of 3D culture systems to recapitulate breast tumor tissue in situ. Cellular Oncology. 47(2). 481–496. 2 indexed citations
3.
Chow, Philip I., Shayna L. Showalter, Matthew S. Gerber, et al.. (2020). Use of Mental Health Apps by Patients With Breast Cancer in the United States: Pilot Pre-Post Study. JMIR Cancer. 6(1). e16476–e16476. 20 indexed citations
4.
Meneveau, Max O., Gina R. Petroni, Nikole Varhegyi, et al.. (2020). Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT. Brachytherapy. 19(5). 679–684. 11 indexed citations
5.
Brenin, David R., Jill R. Dietz, Jennifer Baima, et al.. (2020). Pain Management in Breast Surgery: Recommendations of a Multidisciplinary Expert Panel—The American Society of Breast Surgeons. Annals of Surgical Oncology. 27(12). 4588–4602. 23 indexed citations
6.
Brenin, David R., James T. Patrie, Jonathan V. Nguyen, & Carrie M. Rochman. (2019). Treatment of Breast Fibroadenoma with Ultrasound-Guided High-Intensity Focused Ultrasound Ablation: A Feasibility Study. Journal of Breast Imaging. 1(4). 316–323. 7 indexed citations
7.
McDonald, Oliver G., et al.. (2018). ERα-Mediated Nuclear Sequestration of RSK2 Is Required for ER+ Breast Cancer Tumorigenesis. Cancer Research. 78(8). 2014–2025. 18 indexed citations
8.
Chow, Philip I., Shayna L. Showalter, Matthew S. Gerber, et al.. (2018). Use of Mental Health Apps by Breast Cancer Patients and Their Caregivers in the United States: Protocol for a Pilot Pre-Post Study. JMIR Research Protocols. 8(1). e11452–e11452. 8 indexed citations
9.
Martin, Allison N., et al.. (2017). Anti‐Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer. Case Reports in Oncological Medicine. 2017(1). 8120689–8120689. 5 indexed citations
10.
Dillon, Patrick M., Gina R. Petroni, Mark E. Smolkin, et al.. (2017). A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer. Journal for ImmunoTherapy of Cancer. 5(1). 92–92. 50 indexed citations
11.
Campbell, James, Mingzong Li, Li Yu, et al.. (2016). Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 15(11). 2598–2608. 47 indexed citations
12.
Trifiletti, Daniel M., Timothy N. Showalter, Bruce Libby, et al.. (2015). Intraoperative breast radiation therapy with image guidance: Findings from CT images obtained in a prospective trial of intraoperative high-dose-rate brachytherapy with CT on rails. Brachytherapy. 14(6). 919–924. 12 indexed citations
13.
Brenin, David R.. (2015). Treatment of breast fibroadenoma with high intensity focused ultrasound (HIFU): a feasibility study. Journal of Therapeutic Ultrasound. 3(S1).
15.
Brenin, David R.. (2011). Focused Ultrasound Ablation for the Treatment of Breast Cancer. Annals of Surgical Oncology. 18(11). 3088–3094. 14 indexed citations
16.
McGarvey, Elizabeth L. & David R. Brenin. (2005). Myths about cancer might interfere with screening decisions. The Lancet. 366(9487). 700–702. 3 indexed citations
17.
Ditkoff, Beth Ann, et al.. (2003). The Management of Lobular Neoplasia Identified on Percutaneous Core Breast Biopsy. The Breast Journal. 9(1). 4–9. 63 indexed citations
18.
Winchester, David J., Stephen Sener, David P. Winchester, et al.. (1999). Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients: efficacy of filtered Technetium 99m sulphur colloid with overnight migration time11No competing interests declared.. Journal of the American College of Surgeons. 188(6). 597–603. 102 indexed citations
19.
Brenin, David R., et al.. (1997). Rat embryonic stem cells: A progress report. Transplantation Proceedings. 29(3). 1761–1765. 41 indexed citations
20.
Iannaccone, Philip M., et al.. (1994). Pluripotent Embryonic Stem Cells from the Rat Are Capable of Producing Chimeras. Developmental Biology. 163(1). 288–292. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026